Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

July 16, 2018

Trial Testing Need for Radiotherapy in HER2-Positive Breast Cancer Enrolling Patients

News

Researchers at The University of Kansas Cancer Center have launched a clinical trial evaluating the need for radiation therapy after surgical removal of an aggressive type of breast cancer that ... Read more

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase ... Read more

June 20, 2018

Most Women with Early Breast Cancer Can Forgo Chemotherapy, Large Trial Finds

News

Seventy percent of women with the most common form of early breast cancer can avoid chemotherapy after surgery, according to a landmark Phase 3 clinical trial. The trial’s results, “Adjuvant ... Read more

May 23, 2018

Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials

News

Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according to ... Read more

May 21, 2018

Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds

News

A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The results ... Read more

May 16, 2018May 16, 2018

Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows

News

Researchers have developed a pill that marks tumors and lights them up when exposed to infrared light, which could potentially replace mammography in the future, a study in mice has ... Read more

April 18, 2018

Breast Cancer Patients Need More Help to Manage Cognitive Decline from Chemotherapy, Study Says

News

Almost 50 percent of women with breast cancer have cognitive decline during chemotherapy, and 30 percent have it a year after treatment, according to a recent study. These findings highlight ... Read more

February 16, 2018February 16, 2018

Initial Therapy for Breast Cancer Influences Biopsy Rates During Follow-up, Study Shows

News

Women with breast cancer who undergo breast-conserving surgery and a type of internal radiation therapy known as brachytherapy are more likely to require additional breast biopsies during their follow-up care, a nationwide ... Read more

January 31, 2018

Scientists Report Advances in Light-source Medicine to Help Fight Metastatic Cancer

News

The localized activation of an anti-cancer medicine in tumor cells, through an innovative internal light source, significantly reduced metastatic tumor growth, according to a new study using mice. This response ... Read more

January 12, 2018

Women Working Night Shift Show Increased Risk of Breast Cancer, Meta-analysis Suggests

News

Women who work the night shift have increased odds of developing breast, skin, and gastrointestinal cancer, a new meta-analysis shows. Nurses working night shifts seem to be at even higher ... Read more